Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB. (Q36100081)

12 August 2017

Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB. (English)

1 reference

12 August 2017

Katharina Ronacher

2

0 references

Gerhard Walzl

object named as

Gerhard Walzl

13

0 references

Laura Via

object named as

Laura E Via

11

0 references

author name string

Shubhada Shenai

1

1 reference

12 August 2017

Stefanus Malherbe

3

1 reference

12 August 2017

Kim Stanley

4

1 reference

12 August 2017

Magdalena Kriel

5

1 reference

12 August 2017

Jill Winter

6

1 reference

12 August 2017

Thomas Peppard

7

1 reference

12 August 2017

Charles E Barry

8

1 reference

12 August 2017

Jing Wang

9

1 reference

12 August 2017

Lori E Dodd

10

1 reference

12 August 2017

Clifton E Barry

12

1 reference

12 August 2017

David Alland

14

1 reference

12 August 2017

language of work or name

English

0 references

publication date

10 August 2016

1 reference

12 August 2017

1 reference

12 August 2017

11

1 reference

12 August 2017

8

1 reference

12 August 2017

e0160062

1 reference

Creative Commons CC0 License

12 August 2017

start time

10 August 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

cites work

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Month 2 culture status and treatment duration as predictors of recurrence in pulmonary tuberculosis: model validation and update

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Rapid molecular detection of tuberculosis and rifampin resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Evaluation of the analytical performance of the Xpert MTB/RIF assay.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Biomarkers of treatment response in clinical trials of novel antituberculosis agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Why is long-term therapy required to cure tuberculosis?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Xpert MTB/RIF: monitoring response to tuberculosis treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Requirements for high impact diagnostics in the developing world

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Combining several screening tests: optimality of the risk score.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4980126

Biomarkers for tuberculosis disease activity, cure, and relapse

23 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0160062

Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27508390

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27508390

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0160062

1 reference

12 August 2017

0 references

1 reference

12 August 2017

1 reference